Upcoming CLIAC Meeting
General information and meeting topics are published at least 15 calendar days in advance in the Federal Register, with detailed agendas posted prior to the meeting. Meetings are open to the public and are also webcast.
Please visit this page prior to and during the meeting to access information as it becomes available, such as updated agendas, presentations, and handouts. Public comments can also be submitted in advance of the meeting for consideration by the Committee.
The meeting will be held virtually on November 3, 2021, 11:00 a.m. to 6:00 p.m., EDT and November 4, 2021, 11:00 a.m. to 6:00 p.m., EDT. The agenda will include agency updates from CDC, CMS, and FDA. In addition to the general updates, agency presentations will include an overview of the FDA’s Center for Biologics Evaluation and Research, a laboratory safety update, and a status report on the new CLIA regulations assessment workgroup. Presentations and CLIAC discussion will focus on next generation sequencing in clinical and public health laboratories and laboratory data exchange and harmonization. Please check back for updates.
CLIAC Fall 2021 Virtual Meeting
Wed 11/3/2021 11:00 AM – Thu 11/4/2021 6:00 PM
Virtual meeting on Zoom
Please click the link below to join the webinar:
Or One tap mobile:
US: +16692545252,,1617149815#,,,,*44646137# or +16468287666,,1617149815#,,,,*44646137#
Dial (for higher quality, dial a number based on your current location):
US: +1 669 254 5252 or +1 646 828 7666 or +1 669 216 1590 or +1 551 285 1373
Webinar ID: 161 714 9815
International numbers available: https://cdc.zoomgov.com/u/aPSLMUFDlexternal icon
Or an H.323/SIP room system:
H.323: 184.108.40.206 (US West) or 220.127.116.11 (US East)
Meeting ID: 161 714 9815
It is the policy of CLIAC to accept written public comments and provide a brief period for oral public comments pertinent to agenda items. Public comment periods for each agenda item are scheduled immediately prior to the Committee discussion period for that item.
How to Provide Oral Comments
In general, each individual or group requesting to present an oral comment will be limited to a total time of five minutes (unless otherwise indicated). If you want to make an oral comment during the meeting, email CLIAC@cdc.gov at least five business days prior to the meeting date. All comments will be included in the meeting Summary Report posted on this website.
How to Provide Written Comments
For individuals or groups unable to attend the meeting, CLIAC accepts written comments up to the first day of the meeting. However, it is requested that comments be submitted at least five business days prior to the meeting date so that the comments are available to the Committee for their consideration and public distribution on the CLIAC website. Email comments to CLIAC@cdc.gov or mail comments to the address below. Written comments will be included in the meeting Summary Report posted on this website.
Attention: CLIAC Secretariat
1600 Clifton Road NE
Atlanta, GA 30333